Provention Bio Resubmits Teplizumab Application In US For Type-1 Diabetes
Provention Bio Inc (NASDAQ: PRVB) has
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Cidara Therapeutics (NASDAQ:CDTX) stock moved upwards by 14.1% to $0.91 during Thursday's after-market session. The company's market cap stands at $60.6 million.
52 Biggest Movers From Friday
Gainers
Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share.
Mid-Afternoon Market Update: Gold Records Lowest Finish In Over Six Weeks; Clearfield Shares Gain On Upbeat Results
US stocks gained toward the end of trading session after opening on a weak note. Apple Inc. (NASDAQ: AAPL) reported better-than-expected earnings results for its first quarter after the closing bell on Thursday.
Mid-Day Market Update: US Stocks Turn Positive; Nasdaq Surges 2%
US stocks turned higher, with all the three major indices recording gains. The Nasdaq climbed more than 2% following stronger-than-expected earnings results from Apple Inc. (NASDAQ: AAPL).
33 Stocks Moving In Friday’s Mid-Day Session
Gainers
Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 126% to $2.6219. Imperial Petroleum, last month, posted Q3 revenue of $4.1 million.
FDA Gives Green Signal To Provention Bio’s Delaying Diabetes Med Resubmission
Provention Bio Inc (NASDAQ: PRVB) said that it had resolved the comparability concerns with the FDA, and